Original Research
Accepted on 21 Apr 2025
Toll-like Receptor 3 Activation Enhances Antitumor Immune Response in Lung Adenocarcinoma through NF-κB Signaling Pathway
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Apr 2025
in Cancer Immunity and Immunotherapy
Review
Accepted on 21 Apr 2025
in Nanometrology
Original Research
Accepted on 21 Apr 2025
in Clinical Infectious Diseases
Perspective
Accepted on 21 Apr 2025
in HIV and STIs
Original Research
Accepted on 21 Apr 2025
in Comparative Immunology
Original Research
Accepted on 21 Apr 2025
in Condensed Matter Physics
Mini Review
Accepted on 21 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Apr 2025
in Clinical Infectious Diseases
Original Research
Accepted on 21 Apr 2025
in Higher Education
Review
Accepted on 21 Apr 2025
in Viral Immunology
Clinical Trial
Accepted on 21 Apr 2025
in Inflammation
Original Research
Accepted on 21 Apr 2025
in Gastroenterology
Review
Accepted on 21 Apr 2025
in Pharmacogenetics and Pharmacogenomics
Original Research
Accepted on 21 Apr 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 21 Apr 2025
in Animal Nutrition and Metabolism
Original Research
Accepted on 21 Apr 2025
in Alloimmunity and Transplantation